Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Genix Pharmaceuticals Corp is a Canadian life sciences company engaged in the research, development, manufacturing, and marketing of high growth, high margin, novel and proprietary, evidence-based, pharmaceuticals, over-the-counter products, nutraceuticals and healthcare products, as well as generic medicines. Its product includes Flu-X; Renochlor and Sucanon.
Vancouver, BC, V6E 1J8, Canada